Fig. 3From: Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management programMean total cost per 6 months per patient from societal perspective [€] 6 months before visit 1, and at visits 3 (month 6) and 5 (month 12); patients with available data for all visits (n = 167)Back to article page